YPrime eCOA in Action: Accelerating a Global MDD Clinical Trial Program
300 sites, 40+ countries—four weeks ahead of the FPI
A top 10 clinical trial sponsor needed a trusted electronic clinical outcome assessment (eCOA) expert to manage a complex, large-scale, global three-part program in major depressive disorder (MDD). With numerous international locations and varying regulatory requirements, the sponsor required a partner who could navigate the complexities while ensuring data integrity and consistency across all sites.
YPrime leveraged its industry-leading eCOA platform to deliver a user-friendly solution that prioritized data integrity. The implementation included successful deployment of the visit schedule on handheld devices across nearly 300 sites in 40+ countries, enhancing data quality while prioritizing the patient experience.
Through careful planning and execution, YPrime launched the eCOA system four weeks ahead of the first patient in (FPI). The accelerated timeline and efficient deployment strategy resulted in significant time savings while maintaining budget constraints, ensuring all sites were fully equipped and prepared for trial commencement.
Learn how YPrime’s eCOA platform delivered:
